✦ LIBER ✦

Clinical Utility of the New ASAS Criteria for Spondyloarthritis and the Disease Activity Score

✍ Scribed by Concepción Castillo-Gallego; Sibel Z. Aydin; Helena Marzo-Ortega

Book ID: 107554242
Publisher: Springer
Year: 2011
Tongue: English
Weight: 358 KB
Volume: 13
Category: Article
ISSN: 1523-3774
DOI: 10.1007/s11926-011-0194-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CLINICAL AND LABORATORY CRITERIA FOR THE

CLINICAL AND LABORATORY CRITERIA FOR THE DIAGNOSIS OF BEHÇET'S DISEASE

✍ S. HAIM; A. GILHAR 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Criteria for evaluating the clinical and

Criteria for evaluating the clinical and practical utility of models used by nurses

✍ Desmond FS Cormack; William Reynolds 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 708 KB

Performance of the polymyalgia rheumatic

Performance of the polymyalgia rheumatica activity score for diagnosing disease flares

✍ Binard, Aymeric ;de Bandt, Michel ;Berthelot, Jean-Marie ;Saraux, Alain ;, 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Utility of the new Japanese severity sco

Utility of the new Japanese severity score and indications for special therapies in acute pancreatitis

✍ Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Keiko Kamei; Shumpei Satoi; Hide 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 399 KB

A disease-specific activity index for We

A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score

✍ John H. Stone; Gary S. Hoffman; Peter A. Merkel; Yuan-I Min; Misty L. Uhlfelder; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

The American College of Rheumatology res

The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity

✍ American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 3 views

## Abstract ## Objective Improved standards for the evaluation of therapeutic interventions in systemic lupus erythematosus (SLE) are needed. The purpose of this study by a committee of the American College of Rheumatology was to define clinically meaningful improvement, no change, or worsening in